{"id":46062,"date":"2025-11-07T13:19:13","date_gmt":"2025-11-07T05:19:13","guid":{"rendered":"https:\/\/flcube.com\/?p=46062"},"modified":"2025-11-07T13:19:13","modified_gmt":"2025-11-07T05:19:13","slug":"amacathera-signs-exclusive-global-license-with-pacira-biosciences-for-amt%e2%80%91143-up-to-230-m-deal","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=46062","title":{"rendered":"AmacaThera Signs Exclusive Global License with Pacira BioSciences for AMT\u2011143, Up to $230\u202fM Deal"},"content":{"rendered":"\n<p><strong>AmacaThera<\/strong>, the hydrogel\u2011technology biotech incubated by <strong>Viva BioInnovator (VBI)<\/strong>, announced an exclusive worldwide licensing agreement with <strong>Pacira BioSciences<\/strong>, the leading non\u2011opioid pain\u2011therapy company. The partnership covers <strong>AMT\u2011143<\/strong>, a long\u2011acting, non\u2011opioid anesthetic built on AmacaThera\u2019s next\u2011generation hydrogel drug\u2011delivery platform.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-deal-economics\">Deal Economics<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Component<\/th><th>Amount (USD)<\/th><th>Comments<\/th><\/tr><\/thead><tbody><tr><td><strong>Up\u2011front cash<\/strong><\/td><td><strong>$5\u202fmillion<\/strong><\/td><td>Paid at signing<\/td><\/tr><tr><td><strong>Milestone payments<\/strong><\/td><td><strong>Up to $225\u202fmillion<\/strong><\/td><td>Tied to Phase\u202f2, Phase\u202f3, regulatory and sales milestones<\/td><\/tr><tr><td><strong>Royalty<\/strong><\/td><td>Tiered on net sales<\/td><td>Starts at 5% and steps up to 12% as sales thresholds are met<\/td><\/tr><tr><td><strong>Total potential value<\/strong><\/td><td><strong>$230\u202fmillion<\/strong><\/td><td>Includes upfront, milestones, and royalties<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p>Under the agreement, <strong>AmacaThera<\/strong> will conduct selected early\u2011stage studies, while <strong>Pacira<\/strong> will fund all subsequent development activities through to commercial launch.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-technology-amp-clinical-highlights\">Technology &amp; Clinical Highlights<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>AMT\u2011143<\/strong> delivers <strong>ropivacaine<\/strong> via a proprietary hydrogel matrix, achieving <strong>continuous drug release for up to 14\u202fdays<\/strong> in a Phase\u202f1 safety\/PK study.<\/li>\n\n\n\n<li>The platform is <strong>modular<\/strong>, supporting both <strong>small\u2011molecule anesthetics<\/strong> and <strong>biologic therapeutics<\/strong> for a variety of local\u2011delivery indications.<\/li>\n\n\n\n<li><strong>Phase\u202f2 trial<\/strong> slated for <strong>2026<\/strong>; successful read\u2011out will trigger Pacira\u2019s responsibility for <strong>Phase\u202f3, manufacturing scale\u2011up, and global commercialization<\/strong>.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-rationale\">Strategic Rationale<\/h2>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Pacira<\/strong> expands its non\u2011opioid analgesic pipeline with a differentiated, long\u2011acting formulation that could address postoperative pain, chronic musculoskeletal pain, and outpatient procedures.<\/li>\n\n\n\n<li><strong>AmacaThera<\/strong> gains a <strong>major commercial partner<\/strong> and significant non\u2011dilutive capital, accelerating validation of its hydrogel platform across multiple therapeutic classes.<\/li>\n\n\n\n<li><strong>Viva BioInnovator<\/strong> further validates its incubator model by shepherding portfolio companies to high\u2011value exit or partnership events.<\/li>\n<\/ol>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-impact\">Market Impact<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Analyst outlook:<\/strong> The deal could add <strong>$150\u2011$200\u202fmillion<\/strong> of incremental revenue to Pacira\u2019s 2027\u20112029 forecasts, assuming a modest 1% market penetration in the $20\u202fbillion global postoperative pain market.<\/li>\n\n\n\n<li><strong>Competitive landscape:<\/strong> AMT\u2011143 offers a <strong>single\u2011dose, 14\u2011day analgesic<\/strong> versus current multi\u2011dose regimens, potentially reshaping standard of care and reducing opioid reliance.<\/li>\n\n\n\n<li><strong>Regulatory path:<\/strong> Both companies anticipate filing a <strong>New Drug Application (NDA)<\/strong> in the United States by 2029, with parallel submissions in the EU and China.<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This release contains forward\u2011looking statements regarding the AmacaThera\u2011Pacira agreement, development timelines, and commercial expectations. Actual results may differ due to risks and uncertainties described in the companies\u2019 SEC filings.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>AmacaThera, the hydrogel\u2011technology biotech incubated by Viva BioInnovator (VBI), announced an exclusive worldwide licensing agreement&#8230;<\/p>\n","protected":false},"author":1,"featured_media":46067,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[4437,30,4438,1352],"class_list":["post-46062","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-amacathera","tag-biotech","tag-pacira-biosciences","tag-viva-biotech"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>AmacaThera Signs Exclusive Global License with Pacira BioSciences for AMT\u2011143, Up to $230\u202fM Deal - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"AmacaThera, the hydrogel\u2011technology biotech incubated by Viva Biotech, announced an exclusive worldwide licensing agreement with Pacira BioSciences, the leading non\u2011opioid pain\u2011therapy company. The partnership covers AMT\u2011143, a long\u2011acting, non\u2011opioid anesthetic built on AmacaThera\u2019s next\u2011generation hydrogel drug\u2011delivery platform.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=46062\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AmacaThera Signs Exclusive Global License with Pacira BioSciences for AMT\u2011143, Up to $230\u202fM Deal\" \/>\n<meta property=\"og:description\" content=\"AmacaThera, the hydrogel\u2011technology biotech incubated by Viva Biotech, announced an exclusive worldwide licensing agreement with Pacira BioSciences, the leading non\u2011opioid pain\u2011therapy company. The partnership covers AMT\u2011143, a long\u2011acting, non\u2011opioid anesthetic built on AmacaThera\u2019s next\u2011generation hydrogel drug\u2011delivery platform.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=46062\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-07T05:19:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0705.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46062#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46062\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"AmacaThera Signs Exclusive Global License with Pacira BioSciences for AMT\u2011143, Up to $230\u202fM Deal\",\"datePublished\":\"2025-11-07T05:19:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46062\"},\"wordCount\":376,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46062#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0705.webp\",\"keywords\":[\"AmacaThera\",\"Biotech\",\"Pacira BioSciences\",\"VIVA Biotech\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=46062#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46062\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=46062\",\"name\":\"AmacaThera Signs Exclusive Global License with Pacira BioSciences for AMT\u2011143, Up to $230\u202fM Deal - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46062#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46062#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0705.webp\",\"datePublished\":\"2025-11-07T05:19:13+00:00\",\"description\":\"AmacaThera, the hydrogel\u2011technology biotech incubated by Viva Biotech, announced an exclusive worldwide licensing agreement with Pacira BioSciences, the leading non\u2011opioid pain\u2011therapy company. The partnership covers AMT\u2011143, a long\u2011acting, non\u2011opioid anesthetic built on AmacaThera\u2019s next\u2011generation hydrogel drug\u2011delivery platform.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46062#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=46062\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46062#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0705.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0705.webp\",\"width\":1080,\"height\":608,\"caption\":\"AmacaThera Signs Exclusive Global License with Pacira BioSciences for AMT\u2011143, Up to $230\u202fM Deal\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46062#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AmacaThera Signs Exclusive Global License with Pacira BioSciences for AMT\u2011143, Up to $230\u202fM Deal\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"AmacaThera Signs Exclusive Global License with Pacira BioSciences for AMT\u2011143, Up to $230\u202fM Deal - Insight, China&#039;s Pharmaceutical Industry","description":"AmacaThera, the hydrogel\u2011technology biotech incubated by Viva Biotech, announced an exclusive worldwide licensing agreement with Pacira BioSciences, the leading non\u2011opioid pain\u2011therapy company. The partnership covers AMT\u2011143, a long\u2011acting, non\u2011opioid anesthetic built on AmacaThera\u2019s next\u2011generation hydrogel drug\u2011delivery platform.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=46062","og_locale":"en_US","og_type":"article","og_title":"AmacaThera Signs Exclusive Global License with Pacira BioSciences for AMT\u2011143, Up to $230\u202fM Deal","og_description":"AmacaThera, the hydrogel\u2011technology biotech incubated by Viva Biotech, announced an exclusive worldwide licensing agreement with Pacira BioSciences, the leading non\u2011opioid pain\u2011therapy company. The partnership covers AMT\u2011143, a long\u2011acting, non\u2011opioid anesthetic built on AmacaThera\u2019s next\u2011generation hydrogel drug\u2011delivery platform.","og_url":"https:\/\/flcube.com\/?p=46062","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-11-07T05:19:13+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0705.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=46062#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=46062"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"AmacaThera Signs Exclusive Global License with Pacira BioSciences for AMT\u2011143, Up to $230\u202fM Deal","datePublished":"2025-11-07T05:19:13+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=46062"},"wordCount":376,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=46062#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0705.webp","keywords":["AmacaThera","Biotech","Pacira BioSciences","VIVA Biotech"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=46062#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=46062","url":"https:\/\/flcube.com\/?p=46062","name":"AmacaThera Signs Exclusive Global License with Pacira BioSciences for AMT\u2011143, Up to $230\u202fM Deal - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=46062#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=46062#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0705.webp","datePublished":"2025-11-07T05:19:13+00:00","description":"AmacaThera, the hydrogel\u2011technology biotech incubated by Viva Biotech, announced an exclusive worldwide licensing agreement with Pacira BioSciences, the leading non\u2011opioid pain\u2011therapy company. The partnership covers AMT\u2011143, a long\u2011acting, non\u2011opioid anesthetic built on AmacaThera\u2019s next\u2011generation hydrogel drug\u2011delivery platform.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=46062#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=46062"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=46062#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0705.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0705.webp","width":1080,"height":608,"caption":"AmacaThera Signs Exclusive Global License with Pacira BioSciences for AMT\u2011143, Up to $230\u202fM Deal"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=46062#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"AmacaThera Signs Exclusive Global License with Pacira BioSciences for AMT\u2011143, Up to $230\u202fM Deal"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0705.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/46062","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=46062"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/46062\/revisions"}],"predecessor-version":[{"id":46068,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/46062\/revisions\/46068"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/46067"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=46062"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=46062"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=46062"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}